- Home>
- Journal Watch
- >
- Raynaud's phenomenon
Search for Raynaud's phenomenon in all Journal Watch editions
Physician-authored summaries on the latest research on Raynaud's phenomenon, editorials on Raynaud's phenomenon, and perspectives on Raynaud's phenomenon - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 45 results - Relevance
- Date
You searched for: Raynaud's phenomenon
-
Cryofibrinogenemia — What Is Its Clinical Significance?
- February 24, 2012
- Jeffrey P. Callen, MD
- Dermatology
Many patients with positive CF results have Raynaud phenomenon, but the ramifications are unclear.- Reviewing:
- Soyfoo MS et al., J Rheumatol 2012 Jan; 39:119.
-
Transition from Primary to Secondary Raynaud Phenomenon
- June 30, 2006
- Allan S. Brett, MD
- General Medicine
About 10% of patients with primary RP progressed to secondary RP.- Reviewing:
- Hirschl M et al., Arthritis Rheum 2006 Jun; 54:1974-81.
-
Natural History of Raynaud Phenomenon
- May 6, 2005
- Allan S. Brett, MD
- General Medicine
Raynaud phenomenon (RP) is common in people who do not have underlying connective tissue diseases. In this prospective community-based study of the natural history of . . .- Reviewing:
- Suter LG et al., Arthritis Rheum 2005 Apr; 52:1259-63.
-
Bosentan -- A New Oral Therapy for Severe Raynaud Phenomenon
- January 18, 2005
- Jeffrey P. Callen, MD
- Dermatology
An endothelin antagonist that blocks vasoconstriction looks promising.- Reviewing:
- Korn JH et al., Arthritis Rheum 2004 Dec; 50:3985-93. Ramos-Casals M et al., Rheumatology (Oxford) 2004 Nov; 43:1454-6.
-
Raynaud Phenomenon in Children
- April 30, 2003
- Jeffrey P. Callen, MD
- Dermatology
Raynaud phenomenon (RP) is a painful ischemia in the fingers and toes that is caused by exposure to cold and can occur in patients who . . .- Reviewing:
- Nigrovic PA et al., Pediatrics 2003 Apr; 111:715-21.
-
General Medicine: Nifedipine Better Than Biofeedback for Raynaud's Phenomenon
- July 18, 2000
- TL Schwenk
- Psychiatry
The symptoms of Raynaud's phenomenon (RP) are rarely dangerous but sometimes are sufficiently annoying to warrant treatment. Researchers designed this U.S. multicenter study of 313 . . .- Reviewing:
- Raynaud's Treatment Study Investigators., Arch Intern Med 2000 Apr 24; 160:
1101 1108 .
-
Nifedipine Better Than Biofeedback for Raynaud's Phenomenon
- May 23, 2000
- TL Schwenk
- General Medicine
The symptoms of Raynaud's phenomenon (RP) are rarely dangerous but sometimes are sufficiently annoying to warrant treatment. Researchers designed this U.S. multicenter study of 313 . . .- Reviewing:
- Raynaud's Treatment Study Investigators., Arch Intern Med 2000 Apr 24; 160:
1101 1108 .
-
Does Estrogen Replacement Trigger the Raynaud Phenomenon?
- August 18, 1998
- R Saitz
- General Medicine
Estrogen is thought to have favorable effects on such vascular events as myocardial infarction and cardiac death. Because symptoms of the Raynaud phenomenon seem to . . .- Reviewing:
- Fraenkel L et al., Ann Intern Med 1998 Aug 1; 129:
208 211 .
-
Calcitonin Gene-Related Peptide Treatment for Severe Raynaud's Phenomenon
- September 1, 1993
- JS Dover
- Dermatology
Calcitonin gene-related peptide (CGRP), an alternative product of the calcitonin gene, is widely distributed as a neurotransmitter in the nervous system and is abundant in . . .- Reviewing:
- Bunker CB et al., Lancet 1993; 342:
80 82 .
-
A NEW DRUG FOR RAYNAUD'S PHENOMENON.
- September 26, 1989
- KIM
- General Medicine
Raynaud's phenomenon is treated with a number of medications, including calcium-channel blockers and other vasodilators. Because serotonin (5-hydroxytryptamine) has been shown to be involved in . . .- Reviewing:
- Coffman JD et al., Am J Med 1989 Sep; 87:
264 268 .
-
SECONDARY CONDITIONS WITH RAYNAUD'S PHENOMENON.
- April 22, 1988
- KIM
- General Medicine
Raynaud's phenomenon can be an early manifestation of a connective tissue disease, but secondary diseases often do not develop. This prospective study evaluated 74 patients . . .- Reviewing:
- Fitzgerald O; Hess E V; O'Connor G T; Spencer Green G., Am J Med 1988 Apr; 84:
718 726 .
-
Botox for Raynaud Phenomenon Free
- July 17, 2009
- George J. Hruza, MD
- Dermatology
Results of this treatment were surprisingly long lasting.- Reviewing:
- Neumeister MW et al., Plast Reconstr Surg 2009 Jul; 124:191.
-
Statins Might Benefit Digital Ulcerations and Raynaud Phenomenon
- October 17, 2008
- Jeffrey P. Callen, MD
- Dermatology
These relatively inexpensive agents hold promise for resolving digital ulcers in sclerosis-related Raynaud phenomenon.- Reviewing:
- Abou-Raya A et al., J Rheumatol 2008 Sep; 35:1801.
-
Audiovestibular Manifestations of Limited Systemic Sclerosis
- July 22, 2008
- Robert W. Baloh, MD
- Neurology
In a series of patients with lSSc, audiovestibular findings were most consistent with labyrinthine, rather than nerve, involvement.- Reviewing:
- Amor-Dorado JC et al., Medicine (Baltimore) 2008 May; 87:131.
-
Botox for Raynaud Phenomenon Free
- February 9, 2007
- George J. Hruza, MD
- Dermatology
Injections of botulinum toxin relieved pain and other symptoms in patients with severe cases.- Reviewing:
- Van Beek AL et al., Plast Reconstr Surg 2007 Jan; 119:217-26.
-
Sildenafil for Raynaud’s
- October 3, 2006
- Deborah DeMarco, MD
- General Medicine
Sildenafil significantly improved the microcirculation of patients with Raynaud phenomenon that was resistant to usual vasodilator therapy.- Reviewing:
- Fries R et al., Circulation 2005 Nov 8; 112:2980-5. Mahler F and Baumgartner I., Circulation 2005 Nov 8; 112:2894-5.
-
RAYNAUD'S PHENOMENON, MIGRAINE, AND CHEST PAIN.
- June 30, 1992
- ASB
- General Medicine
Vasospasm is a component of three distinct conditions: Raynaud's phenomenon, migraine headache, and variant angina. This study explored possible relations among these clinical entities.- Reviewing:
- O'Keeffe ST et al., Ann Intern Med 1992 Jun 15; 116:
985 989 .
-
Botulinum Toxin A for Raynaud Syndrome Free
- June 1, 2012
- Murad Alam, MD, MSCI
- Dermatology
Botulinum toxin treatment is worth trying as first-line treatment in Raynaud syndrome.- Reviewing:
- Smith L et al., Arch Dermatol 2012 Apr; 148:426.
-
Are Calcium-Channel Blockers Really Effective for Raynaud's in Systemic Sclerosis?
- October 24, 2001
- JP Callen
- Dermatology
Nifedipine and other calcium-channel blockers have been used for primary and secondary Raynaud's phenomenon (RP), but how well have these agents been studied? Using the . . .- Reviewing:
- Thompson AE et al., Arthritis Rheum 2001 Aug; 44:
1841 1847 .
-
Does Estrogen Replacement Trigger Raynaud's?
- October 1, 1998
- R Saitz
- Dermatology
Estrogen is thought to have favorable effects on such vascular events as myocardial infarction and cardiac death. Because symptoms of Raynaud's phenomenon seem to vary . . .- Reviewing:
- Fraenkel L et al., Ann Intern Med 1998 Aug 1; 129:
208 211 .
Sort by:
Items 1 to 20 of 45 results - Relevance
- Date
